How much is Neurona Therapeutics worth in 2026?

Neurona Therapeutics has a current valuation of $597.0M based on their Later Stage VC round and secondary market data.

How much funding has Neurona Therapeutics raised?

Neurona Therapeutics has raised $347.6M in total funding across 2 funding rounds.

Neurona Therapeutics

Drug DiscoveryWebsite

Neurona Therapeutics valuation and funding history | Last updated: March 28, 2025 | 2 funding rounds

Current Valuation

$597.0M

As of March 28, 2025

Total Funding Raised

$347.6M

Across 2 rounds

Last Round

Later Stage VC

$101.7M

Last Funding

Mar 2025

Funding date

Capital Efficiency

1.72x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
March 28, 2025	Later Stage VC (Series F)	$101.7M	N/A	-
February 6, 2024	Later Stage VC (Series E)	$120.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Neurona Therapeutics is currently valued at $597.0M as of March 28, 2025. The company has raised a total of $347.6M in funding across 2 funding rounds.

Capital Efficiency

With a capital efficiency ratio of 1.72x, Neurona Therapeutics has achieved a valuation that is 1.72 times the total capital raised.

Track Neurona Therapeutics Valuation Updates

Get notified when Neurona Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Neurona Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Neurona Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Neurona Therapeutics Worth in 2026?

Neurona Therapeutics is a leading private company in the Drug Discovery sector. Track Neurona Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Neurona Therapeutics Valuation is Determined

Private company valuations like Neurona Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.